RPL17 and cancer: Ln-γ2, a member of the laminin family of ECM, was transcriptionally activated by TGF-β1 secreted from cancer-associated fibroblasts via JNK/AP1 signaling, and the mediated cell exclusion attenuates the response to anti-PD-1 therapy [42] (Fig. 2A).